AMNEAL PHARMACEUTICALS, INC. Effective Income Tax Rate Reconciliation, Tax Settlement, State and Local, Percent
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Effective Income Tax Rate Reconciliation, Tax Settlement, State and Local, Percent of -7.20% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal · last filed 2025-02-28
- AMNEAL PHARMACEUTICALS, INC. effective income tax rate reconciliation, tax settlement, state and local, percent for fiscal 2024 was -7.20%.
- AMNEAL PHARMACEUTICALS, INC. effective income tax rate reconciliation, tax settlement, state and local, percent for fiscal 2023 was -5.50%.
- AMNEAL PHARMACEUTICALS, INC. effective income tax rate reconciliation, tax settlement, state and local, percent for fiscal 2022 was -0.80%, a 119.05% decline from fiscal 2021.
- AMNEAL PHARMACEUTICALS, INC. effective income tax rate reconciliation, tax settlement, state and local, percent for fiscal 2021 was 4.20%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Settlement, State and Local, Percent 12 month |
|---|---|
| 2024-12-31 | -7.20% 10-K · filed 2025-02-28 |
| 2023-12-31 | -5.50% 10-K · filed 2025-02-28 |
| 2022-12-31 | -0.80% 10-K · filed 2025-02-28 |
| 2021-12-31 | 4.20% 10-K · filed 2024-03-14 |
| 2020-12-31 | -2.00% 10-K · filed 2023-03-03 |
| 2019-12-31 | -15.10% 10-K · filed 2022-03-01 |
| 2018-12-31 | -1.10% 10-K · filed 2021-03-01 |
| 2017-12-31 | 0.00% 10-K · filed 2020-03-02 |
| 2016-12-31 | 0.00% 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |